Fig. 1. In vivo  mean arterial blood pressure (MAP), heart rate (HR), and cardiac output (CO) after administration of 2 mg/kg succinylcholine at time = 0 min for (1) individual MHS animals (MHS 1–5); (2) MHS animals pretreated with 2.5 mg/kg dantrolene (MHS D1 and 2); (3) MHS animals pretreated with 1 mg/kg vecuronium (MHS V1–3); and (4) normals (N 1–5). It can be observed that MAP and CO decreased significantly in MHS and MHS D, but not in MHS V or normals (N). MHS 4 and MHS D2 both required epinephrine therapy at 5 and 7 min, respectively (indicated by number sign). A decrease of MAP and CO in MHS V1 was considered to be caused by an air embolus (indicated by asterisk).

Fig. 1. In vivo  mean arterial blood pressure (MAP), heart rate (HR), and cardiac output (CO) after administration of 2 mg/kg succinylcholine at time = 0 min for (1) individual MHS animals (MHS 1–5); (2) MHS animals pretreated with 2.5 mg/kg dantrolene (MHS D1 and 2); (3) MHS animals pretreated with 1 mg/kg vecuronium (MHS V1–3); and (4) normals (N 1–5). It can be observed that MAP and CO decreased significantly in MHS and MHS D, but not in MHS V or normals (N). MHS 4 and MHS D2 both required epinephrine therapy at 5 and 7 min, respectively (indicated by number sign). A decrease of MAP and CO in MHS V1 was considered to be caused by an air embolus (indicated by asterisk).

Close Modal

or Create an Account

Close Modal
Close Modal